Furthermore, in our own analysis of tumours from the Cancer Genome Atlas, mutations in TP53 and PTEN led to a significant reduction in overall survival in breast cancer patients, a finding not observed with mutations in SYK. This evidence concerns the gene PTEN and breast carcinoma.